[HTML][HTML] Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre
M Schiavoni, M Margaglione, A Coluccia - Blood Transfusion, 2018 - ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOAC) have been shown to be non-inferior to
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
[PDF][PDF] Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre
M Schiavoni, M Margaglione, A Coluccia - Blood Transfus, 2018 - researchgate.net
Background. Direct oral anticoagulants (DOAC) have been shown to be non-inferior to
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre
M Schiavoni, M Margaglione… - Blood transfusion …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Direct oral anticoagulants (DOAC) have been shown to be non-inferior to
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
[引用][C] Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre.
M Schiavoni, M Margaglione, A Coluccia - BLOOD TRANSFUSION, 2017 - fair.unifg.it
Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up
experience in an Italian centre. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
experience in an Italian centre. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo …
Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre
M Schiavoni, M Margaglione, A Coluccia - Blood Transfusion, 2018 - bloodtransfusion.it
Background. Direct oral anticoagulants (DOAC) have been shown to be non-inferior to
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre.
M Schiavoni, M Margaglione… - … = Trasfusione del Sangue, 2017 - europepmc.org
Background Direct oral anticoagulants (DOAC) have been shown to be non-inferior to
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
Use of dabigatran and rivaroxaban in non-valvular atrial fibrillation: one-year follow-up experience in an Italian centre.
M Schiavoni, M Margaglione… - … = Trasfusione del Sangue, 2017 - europepmc.org
Background Direct oral anticoagulants (DOAC) have been shown to be non-inferior to
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …
traditional vitamin K antagonists in preventing stroke and arterial thromboembolism in …